Prenatal Substance Exposure Associated with Problem Behaviors in Middle Childhood

Sarah Maylott, PhD

A collaborative research effort led by Sarah Maylott, PhD of Duke University, suggests that prenatal exposure to substances may increase a child’s risk for displaying problem behaviors in middle childhood. Specifically, children exposed to prenatal tobacco and alcohol were more likely to display rule-breaking or aggressive behaviors, while children exposed to illegal drugs, such as cocaine, methamphetamine, or heroin, were more likely to have higher rates of anxiety, depression, or withdrawn behaviors. However, not all children exposed to substances had behavioral problems, suggesting that some children may be more resilient than others.

This research, titled “Latent Class Analysis of Prenatal Substance Exposure and Child Behavioral Outcomes” is published in the Journal of Pediatrics.

The results outlined in Dr. Maylott’s work are particularly important, as approximately 1 in 5 women in the United States report use of legal or illegal substances while pregnant, varying from tobacco and alcohol to psychoactive drugs, such as opioids and cocaine. Previous studies have investigated how prenatal exposure to multiple substances may affect the health of young children, but less is understood about how polysubstance exposures may affect the neurodevelopment of older children.

Leveraging data from approximately 2,000 women from 10 ECHO cohorts across the country from 2000-2020, the research team used a statistical analysis technique to group women based on the types of substances used during pregnancy and compared these groups based on their child’s behaviors. On average, pregnant women were 28 years old when they gave birth, and child behaviors were assessed between ages 6 to 11 using the Child Behavior Checklist. The team hypothesized that children with prenatal polysubstance exposure would have more instances of problem behavior in middle childhood than those children with little to no prenatal substance exposure.

“Our work shows that it could be possible to identify children with certain behavioral challenges based on their mothers’ prenatal substance use profiles,” said Dr. Maylott. “With further research, clinicians and researchers may be able to use these results to identify and support children at higher risk for behavior problems.”

Subsequent large-scale studies are needed that look at how the quantity and timing of substance use during pregnancy affect children’s risk for behavioral problems and how the home environment may contribute to that risk. Researchers also need to find factors that may lead to resilient outcomes for children with prenatal substance exposure.

Read the research summary.

Exposure to Certain Phthalates During Pregnancy May Affect Brain Development in Infant Girls

<< Back to Research Summaries

Exposure to Certain Phthalates During Pregnancy May Affect Brain Development in Infant Girls

Authors:  Leny Matthew, Craig Newschaffer, et al.

 

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health supported this research.

 

What were the study results?

In this study, researchers found that certain phthalates measured in the infant’s meconium, or first stool, were associated with lower scores on a common test that measures motor, visual, and language skills in girls under age 5.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

What was the study's impact?

This study suggests that prenatal exposure to certain types of phthalates may worsen early childhood learning outcomes for girls but have a neutral or slightly positive effect on boys. By studying meconium, instead of maternal urine, the researchers may be able to capture a longer timeframe of potential pre-natal exposure.

 

Why was the study needed?

Phthalates are widely used in personal care products, cosmetics, plastics, and other household items. These chemicals can cause the body to make substances that are thought to reduce a mother’s level of thyroid hormones, which are critical for fetal brain development. Phthalates are also associated with a reduction in the hormones necessary for sex-specific fetal brain development. Therefore, it is important to test the levels of prenatal phthalate exposure and the potential effects on developing fetuses.

 

Who was involved?

The study involved 956 mother and child pairs from two ECHO research sites—the Safe Passage study (SPS) and the Early Autism Risk Longitudinal Investigation (EARLI). Researchers focused on children who were higher risk for brain and nervous system disorders based on a family history of Autism or exposure to alcohol during pregnancy.

 

What happened during the study?

ECHO researchers measured phthalate levels in meconium from children who had a higher risk for developing brain and nervous system disorders. When the children were 12 months old, researchers tested their motor, visual, and language skills. Researchers used meconium samples rather than the mother’s urine to capture longer-term fetal exposure to phthalates.

 

What happens next?

Future prenatal phthalate exposure studies using meconium samples from newborn infants could investigate the differing effects of phthalate exposure on male versus female infants in order to better understand the reasons why these differences may occur.

 

Where can I learn more?

Access the full journal article, titled “The associations between prenatal phthalate exposure measured in child meconium and cognitive functioning of 12-month-old children in two cohorts at elevated risk for adverse neurodevelopment,” in Environmental Research.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Published November 2022

Read More Research Summaries about Chemical Exposures and Pregnancy

Does prenatal PFAS exposure affect a child’s risk for developing autism-related traits?

Authors: Jennifer Ames, Ghassan Hamra, et al.

Exposures to environmental chemicals and their effect on important molecules during pregnancy

Author(s): Brett T. Doherty, Megan E. Romano, et al.

Assessing Links between Multiple Chemical Exposures during Pregnancy and Birthweight Using Exposure Continuum Mapping

Author(s): John L. Pearce, Brian Neelon, Michael S. Bloom, Jessie P. Buckley, Cande V. Ananth, Frederica Perera, John Vena, and Kelly Hunt

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

Assessment of Chemical Exposures During Pregnancy Using Silicone Wristbands

Author(s): Brett Doherty and Megan Romano

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al

ECHO Study Suggests Exposure to PFAS During Pregnancy May Be Linked to Lower Birthweights

<< Back to Research Summaries

ECHO Study Suggests Exposure to PFAS During Pregnancy May Be Linked to Lower Birthweights

Authors: Amy Padula, Tracey Woodruff, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) program, the Office of the Director, and the National Institutes of Health.

Footnote: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

What were the study results?

PFAS were found in almost all participants in the study. Researchers also found that in this study, participants with higher levels of PFAS exposure were more likely to have babies born with lower birthweight. These results did not find that stress played a role in the relationship between PFAS exposure and birthweight.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

What was this study's impact?

The results of this study suggest that PFAS exposure during pregnancy is associated with lower birthweight in infants. However, outside of research studies, pregnant people are not usually tested for PFAS and are often unaware of their potential harms despite PFAS exposure from the environment being common. Therefore, it is important to address efforts to reduce and prevent further exposure to PFAS. Researchers need to better understand where people are most likely to be exposed to these chemicals given the wide range of exposure sources, from PFAS contamination in water to PFAS used in certain consumer products.

 

Why was this study needed?

It is important to know what the effects of per- and polyfluoroalkyl substances (PFAS) exposures may be on child and maternal health. This study is the largest of its kind and includes participants from across the US to help inform future research related to potential effects of PFAS exposures.

 

Who was involved?

This study included eleven ECHO pregnancy cohorts with a total of 3,339 participants from several states.

 

What happened during the study?

The researchers measured the concentration of PFAS, chemicals used in a wide range of consumer products, in the blood of pregnant women. They also surveyed these women about their stress levels throughout pregnancy. These measurements occurred over the past 20 years. The researchers then compared the birthweight for babies resulting from these pregnancies and recorded any instances of preterm birth.

 

What happens next?

The next step for researchers is to examine potential sources of PFAS exposures, including exposures from drinking water and consumer products. Future studies within ECHO may also examine how body mass index and preexisting conditions, such as diabetes during pregnancy or high blood pressure, may interact with PFAS exposures and contribute to the effects of PFAS on infant birthweight. Future studies may also examine additional chemicals that could contribute to lower birthweight in infants.

 

Where can I learn more?

The US Environmental Protection Agency (EPA) created a Roadmap to protect people and communities from PFAS contamination.

Access the full journal article, titled “Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental influences on Child Health Outcomes (ECHO) Program” in Environmental Health Perspectives.

 

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Published March 15, 2023

 

Access the associated article.

See ECHO's PFAS research.

Read More Research Summaries about Chemical Exposures and Pregnancy

Does prenatal PFAS exposure affect a child’s risk for developing autism-related traits?

Authors: Jennifer Ames, Ghassan Hamra, et al.

Exposures to environmental chemicals and their effect on important molecules during pregnancy

Author(s): Brett T. Doherty, Megan E. Romano, et al.

Assessing Links between Multiple Chemical Exposures during Pregnancy and Birthweight Using Exposure Continuum Mapping

Author(s): John L. Pearce, Brian Neelon, Michael S. Bloom, Jessie P. Buckley, Cande V. Ananth, Frederica Perera, John Vena, and Kelly Hunt

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

Assessment of Chemical Exposures During Pregnancy Using Silicone Wristbands

Author(s): Brett Doherty and Megan Romano

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al

ECHO Researchers Investigate the Effect of Prenatal PFAS Exposure on Birthweight

In a study investigating how per- and polyfluoroalkyl substances (PFAS) exposures affected pregnant mothers and their babies, ECHO researchers Amy Padula, PhD, MSc, and Tracey Woodruff, PhD, MPH, from the University of California, San Francisco found that higher levels of prenatal exposure to PFAS are associated with lower birthweights. The PFAS were detected in all participating mothers, suggesting some level of PFAS exposure from the environment. PFAS are widely used, long lasting chemicals that break down very slowly over time and are found in drinking water, food, household products, personal care products, manufacturing facilities, and other sources.

This research, titled “Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental influences on Child Health Outcomes (ECHO) Program,” is published in Environmental Health Perspectives.

For this study, the researchers collected blood samples and pregnancy data from more than 3,000 pregnant women in 11 different ECHO cohorts. They then measured PFAS levels in the mothers’ blood samples and asked them about their stress levels during pregnancy. The team found that mothers who had higher levels of PFAS chemicals in their bodies were more likely to give birth to a baby of low birth weight than mothers with lower levels of PFAS. Additionally, previous studies have found that psychosocial stress may affect PFAS exposures and birthweight. However, the team did not find that stress played a role in the relationships between low birthweight and PFAS exposure.

This research suggests that PFAS exposures during pregnancy can affect infant birth weight, demonstrating the importance of efforts to reduce sources of environmental PFAS exposure. “Outside of research studies, pregnant people are not tested for PFAS and are uncertain of the potential harms PFAS cause,” said Dr. Padula. “We need to better understand where people are most likely to be exposed to these substances given the number of sources, from drinking water to consumer products.”

The next steps for this research include examining potential sources of PFAS exposure. Additional studies may examine how factors like body mass index and other health conditions in pregnancy might additionally affect the relationship between PFAS exposure and infant birthweight.

The US Environmental Protection Agency (EPA) has created a Roadmap to address PFAS as part of  the Biden Administration plan to accelerate efforts to better protect Americans from PFAS exposure.

Read the research summary.

NIH Program Study Links Prenatal Exposure to Perfluorononanoic Acid with Childhood Autism-related Traits

FOR IMMEDIATE RELEASE

 

Prenatal exposure to perfluorononanoic acid (PFNA), a chemical sometimes found in food or drinking water, is associated with autism-related traits in children, according to a new study funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

PFNA belongs to a group of chemicals known as per- and polyfluoroalkyl substances (PFAS), which are widely used, long-lasting chemicals known as “forever chemicals” because they do not break down easily and can build up in the body over time. To evaluate the relationship between prenatal exposure to PFAS and autism-related traits during childhood, this study looked at 1,224 mother-child pairs from 10 ECHO cohorts across the United States. The researchers measured the levels of eight different PFAS in blood samples collected from mothers during pregnancy. Later, caregivers reported on their child’s autism-related traits.

“By continuously measuring the development of autism-related traits, we were able to examine whether prenatal PFAS exposure may affect the development of autism-related traits, even when a child does not receive a clinical ASD diagnosis,” said Ghassan Hamra, PhD, an ECHO Program investigator at Johns Hopkins Bloomberg School of Public Health.

“In the U.S., exposures to some specific PFAS, such as PFOA and PFOS, have dropped substantially since the industry voluntarily phased these chemicals out in the early 2000s.  However, other PFAS exposures have increased over time,” said Jennifer Ames, PhD, an ECHO Program investigator at the Kaiser Permanente Northern California Division of Research.

Dr. Ames and Dr. Hamra led this collaborative research published in Epidemiology.

Ames, J. et al. Prenatal exposure to per- and polyfluoroalkyl substances and childhood autism-related outcomes. Epidemiology. DOI: 10.1097/EDE.0000000000001587. 

###

About ECHO: ECHO is a nationwide research program supported by the NIH. Launched in 2016, ECHO aims to enhance the health of children for generations to come. ECHO investigators study the effects of a broad range of early environmental influences on child health and development. For more information, visit echochildren.org.

About the NIH: NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information, visit www.nih.gov.

Media Contacts

For information or to request an interview, contact Rebekah Yeager,  rebekah.yeager@nih.gov.

If you are not a member of the media, but have a general inquiry, please contact  NIHKidsandEnvironment@od.nih.gov.

Connect With Us

echo connectorCheck out the recent issues of our bi-monthly newsletter, the ECHO Connector, for program news and the latest research findings.

To receive the ECHO Connector through email, subscribe here.

Follow @ECHOChildHealth for the latest ECHO Program updates on Twitter.

ECHO Study Suggests Prenatal Exposure to Perfluorononanoic Acid (PFNA) May Be Linked to Autism-Related Traits in Children

<< Back to Research Summaries

ECHO Study Suggests Prenatal Exposure to Perfluorononanoic Acid (PFNA) May Be Linked to Autism-Related Traits in Children

Authors: Jennifer Ames, Ghassan Hamra, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health.

 

What were the study results?

The researchers found that prenatal exposure to one specific PFAS chemical, perfluorononanoic acid (PFNA) may be associated with an increase in autism-related traits in children. Prenatal exposure to the mixture of all PFAS chemicals combined was not associated with increased autism-related traits in children.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

What was the study's impact?

This study draws attention to the potential risks of PFAS chemicals on child neurodevelopment.  In the U.S., exposures to some specific PFAS, such as PFOA and PFOS, have dropped substantially since the industry voluntarily phased these chemicals out in the early 2000s. However, other PFAS exposures have increased over time, including thousands of these substances with unknown toxicity. These so-called “forever chemicals” continue to pose risks to health even after they are phased out because they persist in the environment and inside people’s bodies and don’t break down easily. While the estimated effects of PFAS chemicals on child autism-related traits are relatively small in this study, future studies may investigate whether early childhood exposure to PFAS chemicals are associated with effects on other neurodevelopmental outcomes.

 

Why was this study needed?

Per- and polyfluoroalkyl substances (PFAS) are widely used, long lasting chemicals, the components of which break down very slowly over time. Previous studies looking at associations between prenatal PFAS exposure and childhood autism spectrum disorder (ASD) are inconsistent and mostly conducted in small sample sizes.  The objective of this research was to determine whether blood concentrations of PFAS during pregnancy were linked to the development of autism-related traits in children. The researchers in this study were able to examine this question by continuously measuring the development of autism-related traits in a large number of children across the U.S, independently of whether a child received a clinical ASD diagnosis.

 

Who was involved?

The participants of this study included 1,224 mother-child pairs from ten cohorts across the United States. The participants were geographically, racially, and ethnically diverse, and one of the cohorts included families with an increased genetic likelihood of ASD. Most of the participating children were born between 2011 and 2018.

 

What happened during the study?

The researchers measured the levels of eight different PFAS in blood samples collected from mothers during pregnancy. Later, when their children were aged 2.5 years or older, researchers asked caregivers to report on the child’s autism-related traits using a questionnaire called the Social Responsiveness Scale (SRS). The research team tracked the relationship between child SRS scores and prenatal exposure to each individual PFAS as well as the combination of the eight PFAS.

 

What happens next?

Additional research is needed to continue studying the effect of early life exposure to PFAS on child neurodevelopment, including cognition, attention, and other neurobehaviors.  Future studies can also investigate whether biological sex and other factors—such as genetics, underlying health conditions, and nutritional status—may change the effect of PFAS exposure on brain development.

 

Where can I learn more?

Access the full journal article, titled “Prenatal exposure to per- and polyfluoroalkyl substances and childhood autism-related outcomes,” in Epidemiology.

 

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Published January 12, 2023

 

Access the associated article.

See ECHO's PFAS research.

Read More Research Summaries about Chemical Exposures and Pregnancy

Exposures to environmental chemicals and their effect on important molecules during pregnancy

Author(s): Brett T. Doherty, Megan E. Romano, et al.

Assessing Links between Multiple Chemical Exposures during Pregnancy and Birthweight Using Exposure Continuum Mapping

Author(s): John L. Pearce, Brian Neelon, Michael S. Bloom, Jessie P. Buckley, Cande V. Ananth, Frederica Perera, John Vena, and Kelly Hunt

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

Assessment of Chemical Exposures During Pregnancy Using Silicone Wristbands

Author(s): Brett Doherty and Megan Romano

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al

ECHO Researchers Investigate Whether Prenatal Chemical Exposures Affect the Development of Autism-related Traits in Children

Collaborative ECHO research led by Jennifer Ames, PhD of the Kaiser Permanente Northern California Division of Research and Ghassan Hamra, PhD of Johns Hopkins Bloomberg School of Public Health, investigates whether exposures to per- and polyfluoroalkyl substances (PFAS) during pregnancy were associated with the development of autism-related traits in children. The researchers looked at data from 1,224 mother-child pairs and found that prenatal exposure to one specific PFAS chemical, perfluorononanoic acid (PFNA), may be associated with an increase in autism-related traits in children. Prenatal exposure to the mixture of all PFAS chemicals combined was not associated with increased autism-related traits in children. This research, titled “Prenatal exposure to per- and polyfluoroalkyl substances and childhood autism-related outcomes,” is published in Epidemiology.

PFAS are widely used, long lasting chemicals, the components of which break down very slowly over time. Previous studies that have investigated the association between prenatal PFAS exposure and childhood autism spectrum disorder (ASD) have been inconsistent and mostly involved small sample sizes. This study leveraged the large, diverse ECHO-wide cohort to evaluate how prenatal PFAS exposure affects the development autism-related traits, even when a child does not receive a clinical ASD diagnosis.

This study included children born between 2011 and 2018 from 10 racially and ethnically diverse ECHO cohorts across the United States, including one cohort that enrolls children from families with an increased likelihood of ASD. The researchers measured the levels of eight different PFAS in blood samples collected from mothers during pregnancy. Later, when their children were aged 2.5 years or older, researchers asked caregivers to report on their child’s autism-related traits using a questionnaire called the Social Responsiveness Scale (SRS). The research team tracked the associations between these data to examine child SRS scores in relation to each individual PFAS as well as the combination of the PFAS.

“In the U.S. population, exposures to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) have dropped substantially since the industry voluntarily phased out these chemicals in the early 2000s,” said Dr. Ames. “However, other PFAS exposures have increased over time, including thousands with unknown toxicity. These so-called ‘forever chemicals’ continue to pose risks to health even after they are phased out because they persist in the environment and inside people’s bodies and don’t break down easily.”

These results underscore the need for more research on whether PFAS chemicals might have more significant effects on child neurodevelopment, and whether factors such as genetics, underlying health conditions, or nutritional status may change the effect of PFAS exposure on brain development.

Read the research summary.­­

ECHO Study Identifies Depression, Anxiety, and Other Drug Use as Risk Factors for Opioid Use During Pregnancy

<< Back to Research Summaries

ECHO Study Identifies Depression, Anxiety, and Other Drug Use as Risk Factors for Opioid Use During Pregnancy

Authors: Ruby H.N. Nguyen, Monica McGrath, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health.

 

What were the study results?

Most of the participants who used opioids were non-Hispanic White and had at least some college education. Opioid use was more common among people who used tobacco or illegal drugs, and those with a history of depression or anxiety. Additionally, opioid use during pregnancy in this study was rare—only 2.8% of participants used opioids during pregnancy, and the majority of opioid use originated from a prescription.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

What was the study's impact?

This is among the largest observational studies of opioid use during pregnancy thus far, and the diverse sample of pregnant people is more representative of the U.S. population than previous studies. Results from this study strengthened evidence about the co-occurrence of opioid use in pregnancy with depression and use of multiple substances (such as tobacco and illegal drugs). These findings will help to inform further research on screening tools for opioid use during pregnancy. Additionally, the finding that most opioid use originated from prescriptions reinforces the need to reduce the amount of circulating prescription drugs and to better monitor over-prescription of opioids to pregnant people and provide them with alternative treatment solutions for pain management and opioid dependency.

 

Why was this study needed?

Opioids are a class of drugs used as prescription pain relievers that can cause dependence or addiction. The opioid crisis has disproportionately affected women, and use of these drugs can have detrimental effects on women of reproductive ages and on developing fetuses. Previous studies of opioid use during pregnancy have been limited to individuals in specific geographic locations or those with specific types of insurance. The stigmatization of this population has also complicated the collection of data on maternal opioid use during pregnancy. Using a large sample size, this study examined opioid use in a diverse population of pregnant people across the United States to investigate rare exposures – such as polysubstance use - and characteristics associated with opioid use during pregnancy.

 

Who was involved?

This study included over 20,000 pregnant people from 32 ECHO cohorts across the U.S., creating a large and geographically diverse sample.

 

What happened during the study?

The researchers gathered data from pregnant people who were already participants in ECHO cohorts between 1991 and 2021. Medical records, laboratory tests, and self-reports were used to assess opioid use and potentially related factors, such as demographics, use of other substances, and history of anxiety or depression.

 

What happens next?

This study shows that further research is needed on the factors that may lead to use of multiple substances during pregnancy and the association between substance use and depression. This research can help inform the development of screening tools and procedures for identifying individuals who are potentially at risk for opioid use during pregnancy.

 

Where can I learn more?

Access the full journal article, titled “Characteristics of Individuals in the U.S. who Used Opioids during Pregnancy,” in the Journal of Women’s Health.

 

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published November 9, 2022

Access the associated article.

Read More Research Summaries about Pregnancy

Study Reveals Rising Levels of Plastics, Pesticides, and Replacement Chemicals in Pregnant Women

Author(s): Jessie P. Buckley, Tracey J. Woodruff, et al.

Effects of Metal Mixture Exposure During Pregnancy on Fetal Growth

Authors: Caitlin Howe, Margaret R. Karagas, et al.

Exposures to environmental chemicals and their effect on important molecules during pregnancy

Author(s): Brett T. Doherty, Megan E. Romano, et al.

Assessing Links between Multiple Chemical Exposures during Pregnancy and Birthweight Using Exposure Continuum Mapping

Author(s): John L. Pearce, Brian Neelon, Michael S. Bloom, Jessie P. Buckley, Cande V. Ananth, Frederica Perera, John Vena, and Kelly Hunt

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

Assessment of Chemical Exposures During Pregnancy Using Silicone Wristbands

Author(s): Brett Doherty and Megan Romano

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al

NIH Program Study Finds Pregnant People are Exposed to Dangerous Chemicals Found in a Variety of Household Products

FOR IMMEDIATE RELEASE

 

A new National Institutes of Health (NIH)-funded study found that pregnant people are exposed to a variety of dangerous chemicals commonly found in household products. People can be exposed to these chemicals through the air, contaminated food, household dust, water, plastics, products that contain dyes and pigments, and many other sources.

This study used new methods to measure the levels of 45 chemicals in urine samples from 171 pregnant people participating in the NIH Environmental influences on Child Health Outcomes (ECHO) Program. Two of these chemicals, melamine and cyanuric acid, were found in over 99% of study participants, and exposure to four different types of aromatic amines were also found in nearly all participants. Levels of these chemicals were higher among Hispanic and non-Hispanic Black participants and those exposed to tobacco smoke.

“This is the first national study to reveal that pregnant people in the U.S. are widely exposed to melamine, cyanuric acid, and aromatic amines—chemicals that may be harmful to maternal health and child development,” said Giehae Choi, PhD.

ECHO Program investigators Dr. Choi and Jessie Buckley, PhD, both of Johns Hopkins University, along with Tracey Woodruff, PhD, MPH of the University of California, San Francisco led this collaborative research effort published in Chemosphere.

Choi, G. et al. Exposure to melamine and its derivatives and aromatic amines among pregnant women in the United States: The ECHO Program. Chemosphere. DOI: 10.1016/j.chemosphere.2022.135599

###

About ECHO: ECHO is a nationwide research program supported by the NIH. Launched in 2016, ECHO aims to enhance the health of children for generations to come. ECHO investigators study the effects of a broad range of early environmental influences on child health and development. For more information, visit echochildren.org.

About the NIH: NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information, visit www.nih.gov.

Media Contacts

For information or to request an interview, contact Rebekah Yeager,  rebekah.yeager@nih.gov.

If you are not a member of the media, but have a general inquiry, please contact  NIHKidsandEnvironment@od.nih.gov.

Connect With Us

echo connectorCheck out the recent issues of our bi-monthly newsletter, the ECHO Connector, for program news and the latest research findings.

To receive the ECHO Connector through email, subscribe here.

Follow @ECHOChildHealth for the latest ECHO Program updates on Twitter.

ECHO Study Reveals Pregnant People Are Exposed to Dangerous Chemicals Found in a Variety of Household Products

<< Back to Research Summaries

ECHO Study Reveals Pregnant People Are Exposed to Dangerous Chemicals Found in a Variety of Household Products

Authors: Giehae Choi, Jessie Buckley, Tracey Woodruff, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health.

 

What were the study results?

Melamine and cyanuric acid were found in over 99% of the study participants. Four types of aromatic amines were also found in nearly all pregnant participants. Levels of these chemicals were higher among Hispanic and non-Hispanic Black participants and in those exposed to tobacco smoke. For example, levels of 3,4-dichloroaniline—a chemical used in the production of dyes and pesticides—were more than 100% higher among Black and Hispanic women compared to White women.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

What was the study's impact?

This is the first national study to reveal that pregnant people in the U.S. are widely exposed to melamine, cyanuric acid, and aromatic amines—chemicals that may be harmful to maternal health and child development. This raises concerns for the health of pregnant people and babies.

 

Why was this study needed?

Chemicals like melamine, cyanuric acid, and aromatic amines are commonly used to make a variety of household products. Melamine can be found in dishware, plastics, flooring, kitchen counters, and pesticides. Cyanuric acid can be found in disinfectants, plastics, and swimming pools. And aromatic amines can be found in hair coloring, mascara, tattoo ink, paints, tobacco smoke, and diesel fumes. People can be exposed to these chemicals through the air, contaminated food, household dust, water, plastics, products that contain dyes and pigments, and many other sources.

Melamine was globally recognized as toxic after baby formula poisoning incidents in 2007 to 2008, which resulted in health problems in children including kidney stones, kidney failure, and in some cases, death. Research suggests that melamine may also be linked to reduced brain development. There is limited research on the effects of melamine on adults, although preliminary evidence suggests that it may be linked to cancer and other negative health outcomes. Prior studies on melamine were only conducted among pregnant people in Asian countries or limited to non-pregnant people in the U.S Despite melamine’s potential harm and common use in household products, population-level exposure is not regularly monitored in the U.S.

 

Who was involved?

This study included 171 pregnant people from nine ECHO cohorts located in California, Georgia, Illinois, New Hampshire, New York, and Puerto Rico. Of these participants, 40% were Hispanic, 34% were White, 20% were Black, 4% were Asians, and the remaining 2% were from other or multiple racial groups.

 

What happened during the study?

Researchers measured the levels of 45 chemicals in urine samples collected from participants during pregnancy. They used new methods to capture the levels of these chemicals in the urine samples, even those present in small amounts. Then, the researchers compared chemical levels across participants with different sociodemographic backgrounds.

 

What happens next?

Researchers are expanding on this study to look at the effects of higher exposures to these chemicals during pregnancy in over 1,700 pregnant people and investigate whether these exposures are linked with child health outcomes.

 

Where can I learn more?

Access the full journal article, titled “Exposure to melamine and its derivatives and aromatic amines among pregnant women in the United States: The ECHO Program,” in Chemosphere.

Published August 30, 2022

Access the associated article.

Read More Research Summaries about Chemical Exposures and Pregnancy

Study Reveals Rising Levels of Plastics, Pesticides, and Replacement Chemicals in Pregnant Women

Author(s): Jessie P. Buckley, Tracey J. Woodruff, et al.

Effects of Metal Mixture Exposure During Pregnancy on Fetal Growth

Authors: Caitlin Howe, Margaret R. Karagas, et al.

Exposures to environmental chemicals and their effect on important molecules during pregnancy

Author(s): Brett T. Doherty, Megan E. Romano, et al.

Assessing Links between Multiple Chemical Exposures during Pregnancy and Birthweight Using Exposure Continuum Mapping

Author(s): John L. Pearce, Brian Neelon, Michael S. Bloom, Jessie P. Buckley, Cande V. Ananth, Frederica Perera, John Vena, and Kelly Hunt

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

Assessment of Chemical Exposures During Pregnancy Using Silicone Wristbands

Author(s): Brett Doherty and Megan Romano

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al